Either way, the NAION docket in New Jersey, which is handling cases from plaintiffs all over the country, will continue to grow, with or without a new MDL
Yes, GLP-1 medication can be utilized for weight loss in individuals without metabolic disorders like type 2 diabetes
Within a few days, you would receive your medication
It seems to help reduce the activity of tyrosinase, an enzyme that is involved in the synthesis of melanin, leading to a lighter skin tone and diminished dark spots
EVIDENCE SECTION: Cite STEP trials, SELECT trial (cardiovascular benefit), professional guidelines (AACE (American Association of Clinical Endocrinology), Endocrine Society), and FDA approval information
Due to the rising demand for GLP-1 receptor agonists, many patients are now considering switching from Mounjaro to Wegovy